| wsnewspublishers PlasmaTech Biopharmaceuticals, declared that it closed the formerly declared equity financing of $10 million of common stock at a price of $8.00 per share, or 1,250,000 shares, and warrants to purchase 625,000 shares of common stock. The warrants have … |
